1. |
Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer antiapoptosis gene survivin in human and mouse proliferation [J]. Am J Pathol,1998; 152(1)∶43.
|
2. |
Konno R, Yamakawa H, Utsunomiya H, et al. Expression of survivin and bcl2 in the normal human endometrium [J]. Mol Hum Reprod,2000; 6(6)∶529.
|
3. |
Uren AG, Beilharz T, O’connell MJ, et al. Role for yeast inhibitor of apoptosis (IAP)like proteins in cell division [J]. Proc Natl Acad Sci USA, 1999; 96(18)∶10170.
|
4. |
Fraser AG, James C, Evan GI, et al. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR1 plays a conserved role in cytokinesis [J]. Curr Biol, 1999; 9(6)∶292.
|
5. |
Takahashi R, Deveraux Q, Tamm I, et al. A single BIR domain of XIAP sufficient for inhibiting caspases [J]. J Biol Chem, 1998; 273(14)∶7787.
|
6. |
Li F, Altieri DC. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycledependent expression [J]. Cancer Res, 1999; 59(13)∶3143.
|
7. |
Conway EM, Pollefeyt S, Cornelissen J, et al. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions [J]. Blood, 2000; 95(4)∶1435.
|
8. |
Kobayashi K, Hatano M, Otaki M, et al. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation [J]. Proc Natl Acad Sci USA, 1999; 96(4)∶1457.
|
9. |
Ambrosini G, Adida C, Altieri DC, et al. A novel antiapoptosis gene, survivin expressed in cancer and lymphoma [J]. Nat Med, 1997; 3(8)∶917.
|
10. |
Verdecia MA, Huang H, Dutil E, et al. Structure of the human antiapoptotic protein survivin reveals a dimeric arrangement [J]. Nat Struct Biol,2000; 7(7)∶602.
|
11. |
Mahotka C, Wenzel M, Springer E, et al. survivindeltaEx3 and survivin2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties [J]. Cancer Res, 1999; 59(24)∶6097.
|
12. |
Tamm I, Wang Y, Sausville E, et al. IAPfamily protein survivin inhibits caspase activity and apoptosis induced by Fas(CD95), Bax, caspases, and anticancer drugs [J]. Cancer Res, 1998; 58(23)∶5315.
|
13. |
Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase3/p21 complex formation as a result of interaction with CDK4to resist Fasmediated cell death [J]. Oncogene, 2000; 19(10)∶1346.
|
14. |
Suzuki A, Hayashida M, Ito T, et al. Survivin initiates cell cycle entry by the competitive interaction with CDK4/p16(INK4a) and CDK2/cyclin E complex activation [J]. Oncogene, 2000; 19(29)∶3225.
|
15. |
Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin [J]. Nature, 1998; 396(6711)∶580.
|
16. |
Ito T, Shiraki K, Sugimoto K, et al. Survivin promotes cell proliferation in human hepatocellular carcinoma [J]. Hepatology, 2000; 31(5)∶1080.
|
17. |
Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma [J]. Gut, 2000; 46(5)∶645.
|
18. |
Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer [J]. Cancer Res, 1998; 58(22)∶5071.
|
19. |
Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas [J]. Clin Cancer Res, 2000; 6(1)∶127.
|
20. |
Monzo M, Roseu R, Felip E, et al. A novel antiapoptosis gene:Reexpression of survivin messenger RNA as a prognosis marker in nonsmallcell lung cancer [J]. J Clin Oncol, 1999; 17(7)∶2100.
|
21. |
Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas [J]. Cancer Res, 1998; 58(9)∶1808.
|
22. |
Saitoh Y, Yaginuma Y, Ishikawa M. Analysis of bcl2, Bax and survivin genes in uterine cancer [J]. Int J Oncol, 1999; 15(1)∶137.
|
23. |
Islam A, Kageyama H, Takada N, et al. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma [J]. Oncogene, 2000; 19(5)∶617.
|
24. |
Grossman D, McNiff JM, Li F, et al. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line [J]. Lab Invest, 1999; 79(9)∶1121.
|
25. |
Swana HS, Grossman D, Anthony JN, et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer [J]. N Engl J Med, 1999; 341(6)∶452.
|
26. |
Tran J, Rak J, Sheehan C, et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells [J]. Biochem Biophys Res Commun, 1999; 264(3)∶781.
|
27. |
Papapetropoulos A, Fulton D, Mahboubi K, et al. Angiopoietin1 inhibits endothelial cell apoptosis via the Akt/survivin pathway [J]. J Biol Chem, 2000; 275(13)∶9102.
|
28. |
O’connor DS, Schechner JS, Adida C. Control of apoptosis during angiogenesis by survivin expression in endothelial cells [J]. Am J Pathol, 2000; 156(2)∶393.
|
29. |
Buolamwini JK. Novel anticancer drug discovery [J]. Curr Opin Chem Biol, 1999; 3(4)∶500.
|
30. |
Olie RA, SimoesWust AP, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy [J]. Cancer Res, 2000; 60(11)∶2805.
|
31. |
Chen J, Wu W, Tahir SK, et al. Downregulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorageindependent growth [J]. Neoplasia, 2000; 2(3)∶235.
|
32. |
Ambrosini G, Adida C, Sirugo G, et al. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting [J]. J Biol Chem, 1998; 273(18)∶11177.
|